OS Therapies Incorporated (OSTX)
NYSEAMERICAN: OSTX · Real-Time Price · USD
1.700
-0.190 (-10.05%)
At close: Feb 21, 2025, 4:00 PM
1.750
+0.050 (2.94%)
After-hours: Feb 21, 2025, 7:54 PM EST
OS Therapies Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for OS Therapies stock have an average target of 17.5, with a low estimate of 15 and a high estimate of 20. The average target predicts an increase of 929.41% from the current stock price of 1.70.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for OS Therapies stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +1,076.47% | Feb 20, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +1,076.47% | Feb 4, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +1,076.47% | Jan 30, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $8 → $15 | Strong Buy | Maintains | $8 → $15 | +782.35% | Jan 16, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +1,076.47% | Jan 15, 2025 |
Financial Forecast
Revenue This Year
139.74K
Revenue Next Year
37.40M
from 139.74K
Increased by 26,663.99%
EPS This Year
-1.09
from -0.74
EPS Next Year
0.72
from -1.09
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 431,550 | 115.5M | 33.9M |
| Avg | 139,740 | 37.4M | 26.4M |
| Low | n/a | n/a | 20.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | 82,553.5% | -9.4% |
| Avg | - | 26,664.0% | -29.5% |
| Low | - | - | -46.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.67 | 3.10 | 0.46 |
| Avg | -1.09 | 0.72 | 0.05 |
| Low | -1.83 | -0.60 | -0.25 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | -35.9% |
| Avg | - | - | -92.5% |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.